Loading data
ANTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 24.77 m USD | 40.49 m USD | 54.87 m USD | 28.51 m USD | 16.16 m USD |
| Operating profit | -38.11 m USD | -56.79 m USD | -69.64 m USD | -42.26 m USD | -21.57 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -35.17 m USD | -51.32 m USD | -64.73 m USD | -40.96 m USD | -21.54 m USD |
| Net income attributable to common shareholders | -35.17 m USD | -51.32 m USD | -64.73 m USD | -42.78 m USD | -28.06 m USD |
| Basic earnings per share | -1.16 USD/share | -1.72 USD/share | -2.74 USD/share | -2.79 USD/share | -10.64 USD/share |
| Diluted earnings per share | -1.16 USD/share | -1.72 USD/share | -2.74 USD/share | -2.79 USD/share | -10.64 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.